Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Anna E. Marneth"'
Publikováno v:
Frontiers in Hematology, Vol 3 (2024)
Although the involvement of glycan structures in diseases has long been recognized, their detailed and high-throughput investigation has only recently been made possible due to technological advancements. For this reason, glycosylation is a generally
Externí odkaz:
https://doaj.org/article/f89846b58b844d87a675276b1b42b307
Publikováno v:
Frontiers in Molecular Biosciences, Vol 11 (2024)
Externí odkaz:
https://doaj.org/article/14c8901f764747f4a4997f90636fb002
Autor:
Julie Ng, Anna E. Marneth, Alec Griffith, Daniel Younger, Sailaja Ghanta, Alan Jiao, Gareth Willis, Junwen Han, Jewel Imani, Bailin Niu, Joshua W. Keegan, Brandon Hancock, Fei Guo, Yang Shi, Mark A. Perrella, James A. Lederer
Publikováno v:
Journal of Innate Immunity, Vol 15, Iss 1, Pp 765-781 (2023)
Novel therapeutics are urgently needed to prevent opportunistic infections in immunocompromised individuals undergoing cancer treatments or other immune-suppressive therapies. Trained immunity is a promising strategy to reduce this burden of disease.
Externí odkaz:
https://doaj.org/article/12ec38b6a3d0419793c624e7617e2e10
Autor:
Anna E. Marneth, Ann Mullally
Publikováno v:
Haematologica, Vol 105, Iss 8 (2020)
Externí odkaz:
https://doaj.org/article/8d8a195321934f5bbe8e957715f12fd1
Autor:
Rinske van Oorschot, Marten Hansen, Johanna M. Koornneef, Anna E. Marneth, Saskia M. Bergevoet, Maaike G.J.M. van Bergen, Floris P.J. van Alphen, Carmen van der Zwaan, Joost H.A. Martens, Michiel Vermeulen, Pascal W.T.C. Jansen, Marijke P.A. Baltissen, Britta A.P. Laros-van Gorkom, Hans Janssen, Joop H. Jansen, Marieke von Lindern, Alexander B. Meijer, Emile van den Akker, Bert A. van der Reijden
Publikováno v:
Haematologica, Vol 104, Iss 7 (2019)
Dominant-negative mutations in the transcription factor Growth Factor Independence-1B (GFI1B), such as GFI1BQ287*, cause a bleeding disorder characterized by a plethora of megakaryocyte and platelet abnormalities. The deregulated molecular mechanisms
Externí odkaz:
https://doaj.org/article/fa460826edfb42dbb79b809d6ce5fa66
Autor:
Rinske van Oorschot, Anna E. Marneth, Saskia M. Bergevoet, Maaike G.J.M. van Bergen, Kathelijne Peerlinck, Claire E. Lentaigne, Carolyn M. Millar, Sarah K. Westbury, Remi Favier, Wendy N. Erber, Ernest Turro, Joop H. Jansen, Willem H. Ouwehand, Harriet L. McKinney, NIHR BioResource Collaborative Group, Kate Downes, Kathleen Freson, Bert A. van der Reijden
Publikováno v:
Haematologica, Vol 104, Iss 6 (2019)
Externí odkaz:
https://doaj.org/article/ba74c617cb2949d7a1ed47cbed35c732
Autor:
Anna E. Marneth, Lacramioara Botezatu, Judith M. Hönes, Jimmy C.L. Israël, Judith Schütte, Lothar Vassen, Robert F. Lams, Saskia M. Bergevoet, Laura Groothuis, Amit Mandoli, Joost H.A. Martens, Gerwin Huls, Joop H. Jansen, Ulrich Dührsen, Tobias Berg, Tarik Möröy, Christian Wichmann, Mia-Chia Lo, Dong-Er Zhang, Bert A. van der Reijden, Cyrus Khandanpour
Publikováno v:
Haematologica, Vol 103, Iss 9 (2018)
Externí odkaz:
https://doaj.org/article/469be62eb3e14b238b05dea40665f0e6
Autor:
José M. Bastida, María L. Lozano, Rocío Benito, Kamila Janusz, Verónica Palma-Barqueros, Mónica Del Rey, Jesús M. Hernández-Sánchez, Susana Riesco, Nuria Bermejo, Hermenegildo González-García, Agustín Rodriguez-Alén, Carlos Aguilar, Teresa Sevivas, María F. López-Fernández, Anna E. Marneth, Bert A. van der Reijden, Neil V. Morgan, Steve P. Watson, Vicente Vicente, Jesús M. Hernández-Rivas, José Rivera, José R. González-Porras
Publikováno v:
Haematologica, Vol 103, Iss 1 (2018)
Inherited platelet disorders are a heterogeneous group of rare diseases, caused by inherited defects in platelet production and/or function. Their genetic diagnosis would benefit clinical care, prognosis and preventative treatments. Until recently, t
Externí odkaz:
https://doaj.org/article/e0ad23648fa549b5a1e7f34c2c654e55
Autor:
Jonas S. Jutzi, Anna E. Marneth, María José Jiménez-Santos, Jessica Hem, Angel Guerra-Moreno, Benjamin Rolles, Shruti Bhatt, Samuel A. Myers, Steven A. Carr, Yuning Hong, Olga Pozdnyakova, Peter van Galen, Fátima Al-Shahrour, Anna S. Nam, Ann Mullally
Publikováno v:
Leukemia. 37:359-369
Cancer is driven by somatic mutations that provide a fitness advantage. While targeted therapies often focus on the mutated gene or its direct downstream effectors, imbalances brought on by cell-state alterations may also confer unique vulnerabilitie
Autor:
Jonas S. Jutzi, Anna E. Marneth, Michele Ciboddo, Angel Guerra-Moreno, María José Jiménez-Santos, Anastasia Kosmidou, James W. Dressman, Hongyan Liang, Rebecca Hamel, Patricia Lozano, Elisa Rumi, John G. Doench, Jason Gotlib, Anandi Krishnan, Shannon Elf, Fátima Al-Shahrour, Ann Mullally
Publikováno v:
Blood
Calreticulin (CALR) mutations are frequent, disease-initiating events in myeloproliferative neoplasms (MPNs). Although the biological mechanism by which CALR mutations cause MPNs has been elucidated, there currently are no clonally selective therapie